Global Impact of Monoclonal Antibodies (mAbs) in Children: A Focus on Anti-GD2

SIMPLE SUMMARY: Despite being in use for almost 50 years, monoclonal antibodies face limitations in their implementation in clinical practice, particularly in pediatrics and pediatric cancer. Although technological advancements and research into new therapeutic targets have led to the development of...

Descripción completa

Detalles Bibliográficos
Autores principales: Larrosa, Cristina, Mora, Jaume, Cheung, Nai-Kong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378537/
https://www.ncbi.nlm.nih.gov/pubmed/37509390
http://dx.doi.org/10.3390/cancers15143729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378537/
https://www.ncbi.nlm.nih.gov/pubmed/37509390
http://dx.doi.org/10.3390/cancers15143729

Ejemplares similares